Glenmark to launch clotrimazole cream in the US
This article was originally published in Scrip
Executive Summary
Glenmark Generics' US subsidiary has received final approval from the US FDA for its ANDA for clotrimazole cream 1%. Glenmark's generic version, an AB-rated therapeutic equivalent of Taro Pharmaceutical Industries' clotrimazole cream, will be marketed and distributed in the US immediately, the company said.